Drug
Charcoal clinical trials
- studies test it
- 34
- open now
- 4
- in phase 3
- 5
- first study started
- 2004
Keep track of what changes. Save the Charcoal studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
34 studies that test it; most in 2007 (7)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 7 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 5
- Phase 2
- 12
- Phase 3
- 5
- Phase 4
- 10
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 19
Ocera Therapeutics (7) · Tanabe Pharma Corporation (2) · Masonic Cancer Center, University of Minnesota (2) · Astellas Pharma Inc (2) · Chang Gung Memorial Hospital (2) · State University of New York - Upstate Medical University (1) · Conmed Pharmaceutical & Bio-Medical Corporation (1) · Centre Hospitalier Universitaire de Saint Etienne (1)
Often tested with
Tested in the same studies.
AST 120 (18) · Tap Water (1) · Apple juice (1) · Rivaroxaban (1) · Edivoxetine (1) · Decoglurant (1) · Roxadustat (1) · Teriflunomide (1)
Studies
Open first, then newest update. How each study uses Charcoal is read from its arms, and is right about nine times in ten.
Testing it · 34
- Activated CHARcoal in Poisoned Patient - Pilot TrialRecruitingPhase 4Laval UniversityNCT05471479Written as Activated Charcoal
- AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney DiseaseRecruitingPhase 4Chang Gung Memorial HospitalNCT07182422Written as AST-120 (Kremezin®)
- Activated Charcoal Use in Chronic Kidney Disease PatientsRecruitingPhase 2Mansoura UniversityNCT06906874Written as Activated Charcoal
- The Effect of Probiotics vs Activated Charcoal in the Management of CKD Patients Suffering From Uremic Pruritus.Not yet recruitingPhase 2Ain Shams UniversityNCT06579066Written as Activated Charcoal
- A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)CompletedPhase 3Tanabe Pharma CorporationNCT00500682Written as AST-120
- A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)CompletedPhase 3Tanabe Pharma CorporationNCT00501046Written as AST-120
- Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral AnticoagulantsWithdrawnPhase 4University Hospital, AngersNCT02969746Written as Activated Charcoal
- Does a Soft Drink Mixture Improve Tolerance of Activated Charcoal in the Adult Poisoned Patient Without Affecting EfficacyCompletedPhase 4State University of New York - Upstate Medical UniversityNCT06219967Written as Activated Charcoal
- A Pilot Feasibility Study of Activated Charcoal in Healthy VolunteersCompletedEarly Phase 1Masonic Cancer Center, University of MinnesotaNCT04204772Written as Activated charcoal and Tap Water
- AST-120 in Hemodialysis Patients With Uremic PruritusCompletedPhase 4Conmed Pharmaceutical & Bio-Medical CorporationNCT04639674Written as AST-120
- Non Inferiority Study of a Reduced Dose of Activated Charcoal on Rivaroxaban Pharmacokinetics.CompletedPhase 1Centre Hospitalier Universitaire de Saint EtienneNCT04767776Written as Activated charcoal
- Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney DiseaseStatus unknownPhase 2/3Waleed Khaild Rahman Kareem Al-kabiNCT05540431Written as Activated Charcoal
- Effects of CharcoCaps® (Activated Charcoal) vs. Placebo on Intestinal Gas ProductionCompletedNot applicableUniversity of MemphisNCT05510778Written as Charcocaps
- Charcoal in Lung Cancer Patients Undergoing TEMLAWithdrawnPhase 2Masonic Cancer Center, University of MinnesotaNCT04928950Written as Activated charcoal
- Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and PhosphorousStatus unknownPhase 2Assiut UniversityNCT04311645Written as Activated charcoal
- A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy SubjectsCompletedPhase 1Eli Lilly and CompanyNCT01389752Written as Activated Charcoal
- Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With MalariaCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT01955382Written as Actidose Aqua
- A Study on The Effect of Multiple Doses of Activated Charcoal on The Pharmacokinetics of a Single Dose of RO4995819CompletedPhase 1Hoffmann-La RocheNCT01409369Written as activated charcoal
- Pharmacokinetic Study of ASP1517 With Kremezin®CompletedPhase 1Astellas Pharma IncNCT02693613Written as Kremezin®
- Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple SclerosisCompletedPhase 3SanofiNCT01863888Written as charcoal
See all 34 studies that test Charcoal →
Given in every arm · 6 — Charcoal is usual care beside what is tested
- Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisActive, not recruitingPhase 3SanofiNCT06141473Written as Activated charcoal
- A Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05320094Written as Activated Charcoal with Sorbitol
- Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female SubjectsCompletedPhase 1SanofiNCT03802487Written as Charcoal
- Investigation How CG5503 is Taken up and Excreted From the Body After 2 Minutes Intravenous Infusion With and Without Oral Co-administration of CharcoalCompletedPhase 1Grünenthal GmbHNCT03951987Written as 5 g charcoal powder
- Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA Dry Powder Inhaler to Healthy SubjectsCompletedPhase 1GlaxoSmithKlineNCT02691325Written as Activated charcoal
- Effect of Activated Charcoal on Rivaroxaban Pharmacokinetics in Healthy SubjectsCompletedPhase 1Centre Hospitalier Universitaire de Saint EtienneNCT02657512Written as rivaroxaban and activated charcoal
As the comparator · 2 — what is tested is compared with Charcoal
- Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerCompletedPhase 1Orion Corporation, Orion PharmaNCT01593826Written as Charcoal and Symbicort Turbuhaler
- Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler ForteCompletedPhase 1Orion Corporation, Orion PharmaNCT01627158Written as Charcoal and Symbicort Turbuhaler
Codes
What other systems call Charcoal · ClinicalTrials.gg INT007185
- MeSH (NLM) D002606CharcoalOne source ClinicalTrials.gov
- UNII (FDA) 2P3VWU3H10ACTIVATED CHARCOALConfirmed FDA, Wikidata
- RxNorm 272Confirmed FDA, Wikidata
- Wikidata Q2957662activated charcoalConfirmed FDA, Wikidata
- NCI Thesaurus C77524Activated CharcoalOne source FDA
- DrugBank DB09278One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002606 | Charcoal | One source ClinicalTrials.gov |
| UNII (FDA) | 2P3VWU3H10 | ACTIVATED CHARCOAL | Confirmed FDA, Wikidata |
| RxNorm | 272 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2957662 | activated charcoal | Confirmed FDA, Wikidata |
| NCI Thesaurus | C77524 | Activated Charcoal | One source FDA |
| DrugBank | DB09278 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.